These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6345294)

  • 1. Interferon in acute myelogenous leukaemia: a preliminary report.
    Rohatiner AZ; Balkwill F; Lister TA
    Haematol Blood Transfus; 1983; 28():56-8. PubMed ID: 6345294
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience with human lymphoblastoid interferon in acute myelogenous leukaemia (AML).
    Rohatiner AZ; Balkwill FR; Malpas JS; Lister TA
    Cancer Chemother Pharmacol; 1983; 11(1):56-8. PubMed ID: 6576869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent acute myelogenous leukaemia at a single centre over a 10-year period.
    Davis CL; Rohatiner AZ; Amess J; Lim J; Lister TA
    Haematol Blood Transfus; 1990; 33():339-41. PubMed ID: 2323639
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials of human leukocyte interferon in malignancy.
    Hill NO; Pardue A; Khan A; Aleman C; Hilario R; Hill JM
    Tex Rep Biol Med; 1981-1982; 41():634-40. PubMed ID: 6763370
    [No Abstract]   [Full Text] [Related]  

  • 5. Complete remission in a patient with acute myelogenous leukemia treated with leukocyte alpha-interferon and cimetidine.
    Ankerst J; Fäldt R; Nilsson PG; Flodgren P; Sjögren HO
    Cancer Immunol Immunother; 1984; 17(1):69-71. PubMed ID: 6587932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term remission in acute myelogenous leukaemia.
    Büchner T; Urbanitz D; Emmerich B; Fischer J; Heinecke A; Hiddemann W; Pfreundschuh M; Rühl H; Wendt F
    Lancet; 1984 Mar; 1(8376):571. PubMed ID: 6142291
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current approach to the management of patients with hemato-oncologic diseases].
    Goudsmit R; van der Lelie J; Thomas LL
    Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2057-9. PubMed ID: 3479701
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-interferon antibodies in alpha interferon treated patients with chronic myeloid leukaemia.
    Aitchison R; Allen P; Schey S; Newland AC
    Br J Haematol; 1991 Jul; 78(3):465-7. PubMed ID: 1873235
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Ph'-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (Intron A).
    Alimena G; Morra E; Lazzarino M; Liberati AM; Montefusco E; Inveradi D; Bernasconi P; Mancini M; Grignani F; Bernasconi C
    Cancer Treat Rev; 1988 Jan; 15 Suppl A():21-6. PubMed ID: 3277708
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy for acute myelogenous leukaemia.
    Harris R; Zuhrie SR
    Lancet; 1977 Dec; 2(8050):1228. PubMed ID: 73925
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon-alpha therapy of renal cancer.
    Neidhart JA; Gagen MM; Young D; Tuttle R; Melink TJ; Ziccarrelli A; Kisner D
    Cancer Res; 1984 Sep; 44(9):4140-3. PubMed ID: 6378379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term therapy for acute myelogenous leukaemia in younger patients.
    Lister TA; Rohatiner AZ; Slevin ML; Dhaliwal HS; Bell R; Henry G; Thomas H; Amess J
    Haematol Blood Transfus; 1983; 28():30-5. PubMed ID: 6345288
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of Jackson, Aspden Acute Myeloid Leukaemia model.
    Jackson RR; Birkhead BG; Bell R; Lister TA; Gregory WM
    J Oper Res Soc; 1982 Mar; 33(3):211-6. PubMed ID: 10298533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination by interferon-alpha of malignant clone in chronic myeloid leukaemia.
    Opalka B; Kloke O; Bartram CR; Beer U; Janssen JW; Niederle N; Wandl UB
    Lancet; 1989 Jun; 1(8650):1334. PubMed ID: 2566865
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical studies of alpha-interferons in chronic myelogenous leukemia.
    Talpaz M
    Cancer Treat Rev; 1988 Jan; 15 Suppl A():49-53. PubMed ID: 3277710
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trials referral resource. Clinical trials in adult acute myelogenous leukemia.
    Cheson BD; Nelson AP
    Oncology (Williston Park); 1998 Feb; 12(2):224, 227. PubMed ID: 9507522
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon alfa-2c in chronic myelogenous leukemia (CML): hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML previously resistant to therapy with interferon gamma.
    Herrmann F; Jonas D; Helfrich SG; Lindemann A; Schleiermacher E; Mertelsmann R
    Blut; 1990 Oct; 61(4):226-31. PubMed ID: 2121299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia.
    Kloke O; Becher R; Niederle N
    Blut; 1987 Nov; 55(5):453-8. PubMed ID: 3118992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile chronic myeloid leukaemia and alpha-interferon.
    Aricò M; Nespoli L; Caselli D; Bonetti F; Porta FA; Burgio GR
    Eur J Pediatr; 1989 Jan; 148(4):379-80. PubMed ID: 2707286
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemorrhagic fever with renal syndrome: treatment with recombinant alpha interferon.
    Gui XE; Ho M; Cohen MS; Wang QL; Huang HP; Xie QX
    J Infect Dis; 1987 May; 155(5):1047-51. PubMed ID: 2881968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.